Want to see VENU full AI Analyst Report?
Venu Holding Corporation (VENU) Risk Analysis
Risk Overview Q2, 2026
Source: the company's latest filing for the period ended Jun 30, 2026, filed Aug 13, 2026
Risk Change Over Time
Risk Highlights Q2, 2026
Risk Word Cloud
Risk Factors Full Breakdown - Total Risks 67
- Share Price & Shareholder Rights - Risk 1We are an "emerging growth company" and a "smaller reporting company," and the reduced disclosure requirements applicable to emerging growth companies and smaller reporting companies may make our Common Stock less attractive to investors.
We are an "emerging growth company" as defined in the JOBS Act, and we intend to take advantage of some of the exemptions from reporting requirements that are applicable to other public companies that are not emerging growth companies, including: - being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced "Management's Discussion and Analysis of Financial Condition and Results of Operations" disclosure; - not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting; - not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board or a supplement to the auditor's report providing additional information about the audit and the financial statements; - reduced disclosure obligations regarding executive compensation; and - not being required to hold a non-binding advisory vote on executive compensation or obtain shareholder approval of any golden parachute payments not previously approved. In addition, as an "emerging growth company" the JOBS Act allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies, unless we later irrevocably elect not to avail ourselves of this exemption. We have elected to use this extended transition period under the JOBS Act. As a result, our financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that are applicable to public companies, which may make comparison of our financials to those of other public companies more difficult. We will remain an emerging growth company until the earlier of: (i) the last day of the fiscal year (1) following the fifth anniversary of the completion of our initial public offering, (2) in which we have total annual gross revenue of at least $1.235 billion, or (3) in which we are deemed to be a large accelerated filer, which means the market value of our Common Stock that is held by non-affiliates exceeds $700.0 million as of September 30 of the prior year; and (ii) the date on which we have issued more than $1.0 billion in non-convertible debt during the prior three-year period. We are also a "smaller reporting company," meaning that the market value of our Common Stock held by non-affiliates plus the proposed aggregate amount of gross proceeds to us as a result of our initial public offering is less than $700 million, and our annual revenue was less than $100 million during the most recently completed fiscal year. We are therefore entitled to rely on certain reduced disclosure requirements for as long as we remain a smaller reporting company, including, among other things, providing only two years of audited financial statements in this Annual Report on Form 10-K, and, similar to emerging growth companies, providing reduced disclosure obligations regarding executive compensation. In addition, as long as we are a smaller reporting company with less than $100 million in annual revenue, we would be exempt from the requirement to obtain an external audit on the effectiveness of internal control over financial reporting provided in Section 404(b) of the Sarbanes-Oxley Act. These exemptions and reduced disclosures in our SEC filings due to our status as a smaller reporting company make it harder for investors to analyze our results of operations and financial prospects. To the extent we take advantage of the reduced disclosure obligations available for smaller reporting companies, it may be difficult or impossible to compare our financial statements with other public companies. We will remain a smaller reporting company until the last day of the fiscal year in which (i) the market value of shares of our Common Stock held by non-affiliates exceeds $250 million as of the end of that year's second fiscal quarter, or (ii) our annual revenues exceed $100 million during such completed fiscal year and the market value of our Common Stock held by non-affiliates exceeds $700 million as of the end of that year's second fiscal quarter. Investors may find our find our Common Stock less attractive to the extent we will rely on these exemptions. If some investors find our Common Stock less attractive as a result, there may be a less active trading market for our Common Stock, and our stock price may be more volatile.
- Share Price & Shareholder Rights - Risk 2A significant portion of our total outstanding shares of Common Stock are eligible to be sold into the market in the near future, including pursuant to Rule 144, which could cause the market price of our Common Stock to drop significantly, even if our business is doing well.
Sales of a substantial number of shares of our Common Stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our Common Stock. We have also registered all shares of Common Stock that are reserved for issuance under the Company's Amended and Restated 2023 Omnibus Incentive Compensation Plan. As a result, these shares can be freely sold in the public market upon issuance, subject to volume limitations applicable to affiliates and certain lock-up agreements that our officers and directors are subject to. A sale under Rule 144 or under any other exemption from the Securities Act, if available, or pursuant to subsequent registrations of our shares of Common Stock, may have a depressive effect upon the price of our shares of Common Stock in any active market that may develop. We believe that a significant portion of our total outstanding shares of Common Stock may be sold in the public market without restriction by non-affiliates pursuant to Rule 144 after this offering.
- Share Price & Shareholder Rights - Risk 3Shareholders' ownership interest may be diluted significantly through our efforts to obtain financing and satisfy obligations through issuance of additional shares.
Our Articles of Incorporation authorizes our Board of Directors to issue up to 144,000,000 shares of Common Stock, 1,000,000 shares of Class B Non-Voting Common Stock, and up to 5,000,000 shares of Preferred Stock, of which we have designated 1,342 as Series B 4 Preferred Stock. The power of the Board of Directors to issue shares of Common Stock, Preferred Stock, warrants, or options to purchase shares of Common Stock or Preferred Stock is generally not subject to shareholder approval, except for issuances of more than 20% of the Company's outstanding Common Stock or its voting power. While we have completed several capital raises utilizing multiple financial institutions, we may attempt to raise additional capital by returning to the market to sell shares of Common Stock or Preferred Stock, possibly at a discount to the market price of our Common Stock. These actions may result in dilution of the ownership interests and voting power of existing shareholders, further dilute Common Stock book value, and may delay, defer, or prevent a change of control. Our outstanding shares of Series B Preferred Stock entitle the holders thereof to dividends. Additionally, other series of Preferred Stock may carry the preferred right to our assets upon liquidation, the right to receive dividend payments before dividends are distributed to the holders of Common Stock, superior voting or conversion rights, and the right to the redemption of the shares, together with a premium, prior to the redemption of our Common Stock.
- Share Price & Shareholder Rights - Risk 4If securities analysts do not publish research or reports, or publish unfavorable research or reports, about us, our business, our Common Stock, or our market, the price of shares of our Common Stock and our trading volume could decline.
The trading market for our Common Stock will be influenced by the research and reports that securities analysts publish about us and our business. Equity research analysts may elect not to provide research coverage of our Common Stock, and such lack of research coverage may adversely affect the market price of our Common Stock. In the event we do have equity research coverage, we will not have any control over the analysts, or the content and opinion included in their reports. The price of our stock could decline if one or more analysts covering our business downgrade their evaluations of our Common Stock or issue other unfavorable or inaccurate commentary or research. If one or more analysts cease coverage of the Company or fails to publish reports on us regularly, we could lose visibility in the market for our Common Stock and demand for our Common Stock could decrease, which in turn would cause our stock price or trading volume to decline.
- Share Price & Shareholder Rights - Risk 5Certain provisions in our Governance Documents could make a merger, acquisition, other change in control, tender offer, or proxy contest more difficult and may prevent shareholder attempts to replace or remove our current management, which could depress the trading price of our Common Stock.
Certain provisions in our Articles of Incorporation and our Bylaws (our "Bylaws"; together with our Articles of Incorporation, our "Governance Documents") could depress the trading price of our Common Stock by acting to discourage, delay, or prevent a merger, acquisition, tender offer, proxy contest, or other change in control of us or change in our management that our shareholders may deem favorable or advantageous, including transactions in which shareholders might otherwise receive a premium for their shares. These provisions could limit the price that investors are willing to pay in the future for our Common Stock, thereby depressing the market price of our Common Stock. In addition, because our Board is responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by our shareholders to replace or remove our current management by making it more difficult for shareholders to replace members of our Board. Among other things, these provisions: - permit the Board to establish and change the authorized number of directors and to fill any vacancies and newly created directorships; - authorize the issuance of "blank check" Preferred Stock that our Board could use to implement a shareholder rights plan, or so-called "poison pill," that would work to dilute the stock ownership of a potential hostile acquirer, effectively preventing acquisitions that have not been approved by our Board; - establish advance notice requirements for nominations for election to our Board or for proposing matters that can be acted upon by shareholders at annual shareholder meetings; and - authorize the Board to adopt, amend, or repeal our Bylaws. Any provision in our Governance Documents that has the effect of delaying or deterring a change in control could limit the opportunity for our shareholders to receive a premium for their shares of Common Stock and could also affect the price that some investors are willing to pay for our Common Stock.
- Share Price & Shareholder Rights - Risk 6Our Articles of Incorporation permit "blank check" Preferred Stock, which can be designated by our Board of Directors without shareholder approval.
Our Amended and Restated Articles of Incorporation (our "Articles of Incorporation") authorize the Board to issue up to 5,000,000 shares of Preferred Stock, which may be issued from time to time in one or more series, each of which will have a distinctive designation or title as determined by our Board. To date, we have denominated 1,342 shares of our preferred stock as Series B 4% Cumulative Convertible Preferred Stock ("Series B Preferred Stock"). Our Articles of Incorporation authorize the Board to establish the designations, preferences, limitations, restrictions, and relative rights of the Preferred Stock and any variations in the relative rights and preferences as between different series of Preferred Stock in accordance with the CBCA. As such, the Board could establish one or more individual series of Preferred Stock with enhanced dividend rights, rights of redemption, sinking funds to pay dividends, liquidation, and other rights that would be different than, and preferential to, the rights of the holders of our Common Stock. Because our Board is able to designate the powers and preferences of the Preferred Stock without the vote of a majority of our shareholders, holders of our Common Stock will have no control over what designations and preferences any newly designated Preferred Stock will have.
- Share Price & Shareholder Rights - Risk 7Widespread market volatility and fluctuations in the share price of Venu's Common Stock could expose us to costly securities litigation.
In the past, following periods of market volatility, public company shareholders have often instituted securities class action litigation. If we were involved in securities litigation, it could impose a substantial cost upon us and divert the resources and attention of our management from our business.
- Share Price & Shareholder Rights - Risk 8The stock price of Venu's Common Stock may be volatile or may decline regardless of our operating performance.
An active or liquid market in our Common Stock may not be sustainable. An inactive market may also impair our ability to raise capital by selling shares of our Common Stock and may impair our ability to enter into strategic partnerships or acquire companies or products by using our shares of Common Stock as consideration.
- Share Price & Shareholder Rights - Risk 9Venu's officers, directors, and principal shareholders collectively own a substantial portion of Venu's Common Stock.
Collectively, Venu's officers and directors beneficially own approximately 35.4% of our outstanding Common Stock as of March 15, 2026. Specifically, JW Roth, our Chairman, Chief Executive Officer, and founder, beneficially owns approximately 30.7% of the voting power of our Common Stock; Heather Atkinson, our Chief Financial Officer, Secretary, and one of our directors, beneficially owns approximately 1.6%; Mitchell Roth, one of our directors, beneficially owns approximately 1.6%; and each of our other officers and directors beneficially own less than 1%. As a result, shareholders may face challenges in affecting matters involving our Company, including: - the composition of our Board of Directors and, through it, any determination with respect to our business direction and policies, including the appointment and removal of officers; - any determination with respect to mergers or other business combinations; - our acquisition or disposition of assets; and - our corporate financing activities. Our officers, directors, and principal shareholders may act in concert to significantly influence these and other matters requiring shareholder approval. Furthermore, this concentration of voting power could have the effect of delaying, deterring, or preventing a change of control or other business combination that might otherwise be beneficial to our shareholders. This significant concentration of share ownership may also adversely affect the trading price for our Common Stock because investors may perceive disadvantages in owning stock in a company that is controlled by a small number of shareholders.
- Share Price & Shareholder Rights - Risk 10Any failure by Venu or its subsidiaries to comply with private offering exemption requirements could result in, among other things, rescission rights that could adversely affect the Company as a whole.
The offer and sale of securities and investment related products by entities and their agents is subject to numerous regulations under federal and state securities laws. From time to time Venu's subsidiaries engage in private offerings of securities of membership interests and that relate to its Luxe FireSuites, and, when it does so to the extent any offerings involve a sale of securities Company seeks to offer and sell those securities in reliance upon certain private offering exemptions from registration provided in the Securities Act and related exemptions under applicable state securities laws. If the Company (or any applicable subsidiary) fails to comply with the requirements of such offering exemption(s), the Company could be subject to certain claims by federal or state securities regulators and investors may have the right, if they so desired, to rescind their purchase of the membership interests they purchase (and any corollary Luxe FireSuite rights). This rescission right might also apply under the applicable state securities or "blue sky" laws and regulations in states where the any securities are offered. In addition, certain Venu subsidiaries may offer use rights or other interests in Luxe FireSuites located at certain of Venu's projects that Venu does not believe are a security, but, could later to be deemed subject to regulation under federal or state securities laws. Any failure to comply with applicable securities laws could subject the Company to various sanctions, fines and penalties. In addition, if a number of investors were successful in seeking rescission, the Company (or applicable subsidiary) could face severe financial demands that would adversely affect a given project, or even the Company as a whole.
- Share Price & Shareholder Rights - Risk 11If certain communications used to market certain exempt offerings of membership interests conducted by the Company's subsidiaries are deemed to have been an "offer" in violation of Section 5 of the Securities Act with respect to any public offering that the Company conducts, the Company may be subject to claims for rescission by investors that participate in the public offering.
Certain of the Company's special purpose entity ("SPE") subsidiaries have conducted exempt private offerings of membership interests ("Subsidiary Offerings"). The Subsidiary Offerings have often been generally referenced by the Company as "Luxe FireSuite" sales (with a key focus being on a holder's right to use and "own" a specific Luxe FireSuite in a specific amphitheater and on the real property asset owned by the particular SPE subsidiary). Having third parties' own certain stakes or rights in SPE assets and being afforded various in-kind rights and benefits for their use at specific venues, has lent to the Company's general mantra of being "fan owned." In connection with these Subsidiary Offerings, the Company's SPE subsidiaries marketed the Subsidiary Offerings through various general solicitation efforts and communications ("Subsidiary Communications"), including posting references to or information about the Subsidiary Offering investment opportunities to the Company's website, which described the type of security being offered by each specific subsidiary, the venue and geographic location each such Subsidiary Offering related to, and the anticipated benefits to prospective investors in each SPE subsidiary, as well as forms of print or other broadcast media that was generally geographically targeted to prospective investors in a given market where a venue was set to be developed. The Subsidiary Communications related or eluded solely to opportunities in certain of the Company's SPE subsidiaries and, unlike with respect to any public offering that the Company conducts, did not in any way relate to a prospective investment in the Company as a whole, or to the Company's offering of Common Stock at the parent corporation level. The Company does not believe that the Subsidiary Communications and marketing efforts described above constitute a violation of Section 5 of the Securities Act of 1933, as amended (the "Securities Act"), or of applicable provisions of state securities laws. However, if such communications were held by a court to be "offers" in violation of Section 5 of the Securities Act or applicable provisions of state securities laws with respect to any public offering that the Company previously conducted or conducts in the future, purchasers of shares of Common Stock in the public offering may have rescission rights or claims for damages. Upon exercise of any such rescission rights, the Company could be required to repurchase the shares sold to investors in the public offering, for any consideration determined to have been paid for such shares, with interest thereon, less the amount of any income received therefrom, or for damages if the shares are no longer owned by any such investor, for a period of one year following the date of the violation. Similar remedies could be available to investors under state securities laws. The amount of any such potential liability is uncertain. The Company would contest vigorously any claim that a violation of the Securities Act or applicable provisions of state securities law occurred.
See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.
